| Skeletal involvement in type 1 Gaucher disease: Not just bone mineral density M Baldini, G Casirati, FM Ulivieri, E Cassinerio, KK Chalouhi, E Poggiali, ... Blood Cells, Molecules, and Diseases 68, 148-152, 2018 | 29 | 2018 |
| Epitope editing enables targeted immunotherapy of acute myeloid leukaemia G Casirati, A Cosentino, A Mucci, MS Mahmoud, I Ugarte Zabala, J Zeng, ... Nature, 2023 | 27 | 2023 |
| Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia MM Naldini, G Casirati, M Barcella, PMV Rancoita, A Cosentino, ... Nature Communications 14 (1), 1285, 2023 | 22 | 2023 |
| Nanosphere’s Verigene® blood culture assay to detect multidrug-resistant Gram-negative bacterial outbreak: a prospective study on 79 hematological patients in a country with … R Greco, MC Barbanti, N Mancini, L Infurnari, R Pasciuta, A Forcina, ... Clinical Hematology International 1 (2), 120-123, 2019 | 4 | 2019 |
| The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell … A Casirati, I Salcedo, E Cereda, C Chabannon, A Ruggeri, J Kuball, ... Bone Marrow Transplantation 58 (9), 965-972, 2023 | 3 | 2023 |
| IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity E Landoni, MG Woodcock, G Barragan, G Casirati, V Cinella, S Stucchi, ... Nature Communications 15 (1), 89, 2024 | 2 | 2024 |
| Base editing of human hematopoietic stem cells J Zeng, G Casirati, MA Nguyen, P Genovese, DE Bauer Base Editors: Methods and Protocols, 43-62, 2023 | 1 | 2023 |
| Epitope Engineered Hematopoietic Stem and Progenitor Cells to Enable CAR-T Cell Immunotherapy for Acute Myeloid Leukemia G Casirati, A Cosentino, A Mucci, IU Zabala, MS Mahmoud, C Brendel, ... American Society of Hematology Annual Meeting, 303-304, 2022 | 1 | 2022 |
| Dissecting Ex Vivo Expansion of Mobilized Peripheral Blood Hematopoietic Stem and Progenitor Cells By Single Cell RNA Sequencing MM Naldini, G Casirati, E Zonari, G Desantis, A Cammarata, S Beretta, ... Blood 132, 3343, 2018 | 1 | 2018 |
| Endocrinopathies following allogeneic stem cell transplantation: 10 years follow-up in 402 patients MTL Stanghellini, G Vita, A Assanelli, F Lorentino, F Serpenti, R Greco, ... Blood 132, 4600, 2018 | 1 | 2018 |
| Abstract NG05: Epitope editing enables targeted immunotherapy of acute myeloid leukemia G Casirati, A Cosentino, A Mucci, MS Mahmoud, IU Zabala, J Zeng, ... Cancer Research 84 (7_Supplement), NG05-NG05, 2024 | | 2024 |
| Stem cells in disguise Epitope editing can empower targeted cancer immunotherapies G Casirati SCIENCE 383 (6684), 2024 | | 2024 |
| Stem cells in disguise G Casirati Science 383, 714-714, 2024 | | 2024 |
| The Association of SEPTIN6 Mutations with Pediatric Myelodysplasia SF Mohamad, M McGuinness, G Casirati, CE Harris, R Renella, ... Blood 142, 1846, 2023 | | 2023 |
| Epitope Edited Hematopoietic Stem Cells to Enable Synergistic Immunotherapy Combinations for Acute Myeloid Leukemia G Casirati, A Cosentino, A Mucci, MS Mahmoud, IU Zabala, J Zeng, ... Blood 142, 7130, 2023 | | 2023 |
| Epitope Edited Hematopoietic Stem Cells Allow Immune-Based In Vivo Selection of Genome-Engineered Cells G Casirati, A Cosentino, A Mucci, MS Mahmoud, M Freschi, J Zeng, ... Blood 142, 7127, 2023 | | 2023 |
| 237 Epitope engineered hematopoietic stem cells to enable multi-specificity CAR-T cells for acute myeloid leukemia G Casirati, A Cosentino, A Mucci, MS Mahmoud, IU Zabala, J Zeng, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Epitope Editing of Hematopoietic Stem Cells Enables Adoptive Immunotherapies for Acute Myeloid Leukemia G Casirati Università degli Studi di Milano-Bicocca, 2023 | | 2023 |
| Septin-6 Regulates Murine and Human Hematopoiesis, and Its Dysregulation Is Associated with Pediatric Myelodysplasia SF Mohamad, M McGuinness, G Casirati, AE Rodriguez-Fraticelli, ... Blood 140 (Supplement 1), 8588-8589, 2022 | | 2022 |
| ENGINEERING IMMUNOTHERAPY RESISTANT HEMATOPOIESIS TO TREAT HIGH-RISK ACUTE MYELOID LEUKEMIA G Casirati, A Cosentino, L Sereni, V Cinella, A Mucci, C Brendel, ... HUMAN GENE THERAPY 33 (7-8), A8-A8, 2022 | | 2022 |
